Trial Profile
A phase II trial of tivozanib combination therapy in patients with breast cancer.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2011
Price :
$35
*
At a glance
- Drugs Tivozanib (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 07 Nov 2011 New trial record